Practice school session on "GOOD Documentation Practices" dated 08.01.2021 by Mr. Namdeo Shinde
1. Pharmacy Practice School 2021
Session- 01
FORMULATION
&
DEVELOPMENT
Speaker:
Mr. Namdeo G. Shinde
Assistant Professor,
Department of Pharmaceutics,
Satara College of Pharmacy, Degaon,
Satara MS India 415004.
1/8/2021Mr. Namdeo Shinde M. Pharm.
3. The 1972 Devonport, UK, incident resulted in at least five
deaths when drug products designed to be sterile became
contaminated and recipients developed infections.
An unwritten change to autoclave operation,
communicated orally between operators, resulted in
dextrose intravenous solutions that were not uniformly
sterile.
1/8/2021Mr. Namdeo Shinde M. Pharm.
4. 1/8/2021Mr. Namdeo Shinde M. Pharm.
The Clothier inquiry, which examined the causes
and contributing factors, identified several
violations of what we now consider basic good
manufacturing practice (GMP).
5. ‘If it’s not written down,
then it didn’t happen!’
BASIC RULES IN GMP
1/8/2021Mr. Namdeo Shinde M. Pharm.
6. Document is any written statement or
proof of any activity in
pharmaceuticals.
1/8/2021Mr. Namdeo Shinde M. Pharm.
7. Documentation is the key to GMP compliance and
ensures traceability of all development, manufacturing,
and testing activities.
1/8/2021Mr. Namdeo Shinde M. Pharm.
8. Documentation provides the route for auditors to assess
the overall quality of operations within a company and
the final product
1/8/2021Mr. Namdeo Shinde M. Pharm.
9. Documents are a mirror to show actual image of
any pharmaceutical company.
Documents and products are produced in
pharmaceuticals but regulatory bodies are
interested to see documents first.
1/8/2021Mr. Namdeo Shinde M. Pharm.
10. Good documentation is a systematic procedure
of preparation, checking, verifying, issuing,
storing and reviewing of any documents.
1/8/2021Mr. Namdeo Shinde M. Pharm.
11. Batch record is an important document kept along with
reserve sample until one year of expiry of the product,
and final products are release only after proper review of
BMR, even after testing of Product from QC, product
would not be released without review and completing of
BMR and other documents.
Every activity should be available in written form as
SOPs is a requirements of GMP.
1/8/2021Mr. Namdeo Shinde M. Pharm.
12. Clearly written documents prevent errors of various
activities in pharma, each and every activity is written in
specific documents such as SOPs and strictly followed.
Spoken communications may be create errors so that all
important documents such as Master formula record ,
procedure and record must be free from errors and
Documented.
1/8/2021Mr. Namdeo Shinde M. Pharm.
14. Purpose of Documentations:
• Defines specifications and procedures for all materials and
methods of manufacture and control
• Ensures all personnel know what to do and when to do it
• Ensure that authorized persons have all information
necessary for release of product
• Ensures documented evidence, traceability, provide
records and audit trail for investigation
• Ensures availability of data for validation, review and
statistical analysis.
1/8/2021Mr. Namdeo Shinde M. Pharm.
15. Following are the classification of Documents:
For organization & Personnel.
For Buildings & facilities
For Equipments.
For Handling of R.M.& P.M.
For Production & process control.
For Packaging & Labeling control.
For Holding & Distribution
For Laboratory Control.
For Records & Reports.
For Return & Salvaged finished products.
1/8/2021Mr. Namdeo Shinde M. Pharm.
16. Type of documents used in pharmaceuticals
Specifications:
As per MHRA Specifications describe in detail the
requirements with which the products or materials used or
obtained during manufacture have to conform. They serve as
a basis for quality evaluation. We need specification for:
1. Active and inactive materials
2. Primary printed and packing materials
3. Intermediate and semi finished product
4. Finished product
1/8/2021Mr. Namdeo Shinde M. Pharm.
17. It is a written, authorized functional instruction used as
a reference by the person responsible for performance
and are also used for training new operators in the
performance of the procedure.
SOPs:
1/8/2021Mr. Namdeo Shinde M. Pharm.
18. Test method: it is a written and approved documents
describe the detailed testing procedure.
List: Documents contain a catalog of any object such as list
of equipments.
Certificates of Analysis: it is an authentic documents shows
the analytical reports and decision of acceptance/rejections
• Label
• Records
• Organ gram
• Job description
1/8/2021Mr. Namdeo Shinde M. Pharm.
19. It is an important document issued for every batch of product to
assure, review and record keeping of any product batch. There are
following major content of BMR.
1. Name of product, generic name, strength, shelf life,
manufacturing date and exp date.
2. A complete list of ingredients with full description, codes and
quantity to be issued.
3. A statement for theoretical yield and reconciliation.
Batch Manufacturing records:
1/8/2021Mr. Namdeo Shinde M. Pharm.
20. 4. A complete MFG and control instructions, sampling and testing
procedure, specification and precaution to be followed.
5. A statement for processing location and equipment.
6. The method or reference to method to be used for preparing the
critical equipment including cleaning, assembling, calibrating and
sterilizing.
7. Dates and time of all activities
8. Line clearance procedure in every steps
9. Labeling control and specimen for coding in primary, secondary
and tertiary packing materials
10. Deviation record
11. Result of examine made. 1/8/2021Mr. Namdeo Shinde M. Pharm.
22. Good documentation constitutes an essential
part of the quality assurance system.
Clearly written procedures prevent errors
resulting from spoken communication, and
clear documentation permits tracing of
activities performed.
1/8/2021Mr. Namdeo Shinde M. Pharm.
23. Documents must be designed, prepared,
reviewed, and distributed with care.
1/8/2021Mr. Namdeo Shinde M. Pharm.
24. Documents must be approved, signed, and
dated by the appropriate competent and
authorized persons.
1/8/2021Mr. Namdeo Shinde M. Pharm.
25. Documents must have unambiguous contents.
The title, nature, and purpose should be clearly
stated. They must be laid out in an orderly
fashion and be easy to check. Reproduced
documents must be clear and legible.
1/8/2021Mr. Namdeo Shinde M. Pharm.
26. Documents must be regularly reviewed and kept
up-to-date. When a document has been revised,
systems must be operated to prevent
inadvertent use of superseded documents
(e.g., only current documentation should be
available for use).
1/8/2021Mr. Namdeo Shinde M. Pharm.
27. Documents must not be handwritten; however,
where documents require the entry of data, these
entries may be made in clear legible handwriting
using a suitable indelible medium (i.e., not a
pencil). Sufficient space must be provided for
such entries.
1/8/2021Mr. Namdeo Shinde M. Pharm.
28. Any correction made to a document or record
must be signed or initialed and dated; the
correction must permit the reading of the
original information. Where appropriate, the
reason for the correction must be recorded.
1/8/2021Mr. Namdeo Shinde M. Pharm.
29. Record must be kept at the time each action is
taken and in such a way that all activities
concerning the conduct of preclinical studies,
clinical trials, and the manufacture and control
of products are traceable.
1/8/2021Mr. Namdeo Shinde M. Pharm.
30. Storage of critical records must at secure place,
with access limited to authorized persons. The
storage location must ensure adequate
protection from loss, destruction, or
falsification, and from damage due to fire, water,
etc.
1/8/2021Mr. Namdeo Shinde M. Pharm.
31. If documentation is handled by electronic data
processing methods, only authorized persons
should be able to enter or modify data in the
computer, access must be restricted by
passwords or other means, and entry of critical
data must be independently checked.
1/8/2021Mr. Namdeo Shinde M. Pharm.
32. It is particularly important that during the period of
retention, the data can be rendered legible within an
appropriate period of time.
1/8/2021Mr. Namdeo Shinde M. Pharm.
33. If data is modified, it must be traceable.
1/8/2021Mr. Namdeo Shinde M. Pharm.
34. Common types of documents as per GMP
Quality manual:
A global company document that describes, in
paragraph form, the regulations and/or parts of
the regulations that the company is required to
follow.
1/8/2021Mr. Namdeo Shinde M. Pharm.
35. Policies:
Documents that describe in general terms, and not
with step-by-step instructions, how specific GMP
aspects (such as security, documentation, health,
and responsibilities) will be implemented.
1/8/2021Mr. Namdeo Shinde M. Pharm.
36. Standard operating procedures (SOPs):
Step-by-step instructions for performing operational
tasks or activities.
1/8/2021Mr. Namdeo Shinde M. Pharm.
37. Batch records:
These documents are typically used and
completed by the manufacturing department.
Batch records provide step-by-step instructions
for production-related tasks and activities,
besides including areas on the batch record itself
for documenting such tasks.
1/8/2021Mr. Namdeo Shinde M. Pharm.
38. TEST METHODS:
These documents are typically used and
completed by the quality control (QC)
department. Test methods provide step-by-step
instructions for testing supplies, materials,
products, and other production-related tasks
and activities, e.g., environmental monitoring of
the GMP facility.
1/8/2021Mr. Namdeo Shinde M. Pharm.
39. Specifications:
Documents that list the requirements that a
supply, material, or product must meet before
being released for use or sale.
The QC department will compare their test
results to specifications to determine if they pass
the test.
1/8/2021Mr. Namdeo Shinde M. Pharm.
40. LOGBOOKS:
Bound collection of forms used to document activities.
Typically, logbooks are used for documenting the
operation, maintenance, and calibration of a piece of
equipment.
Logbooks are also used to record critical activities, e.g.,
monitoring of clean rooms, solution preparation,
recording of deviation, change controls and its
corrective action assignment.
1/8/2021Mr. Namdeo Shinde M. Pharm.